
(Part three of a four-part series)
As for ketamine-assisted therapy, biotech psychedelics company Awakn Life Sciences (OTC:AWAKNF) offers two distinct protocols. One is called KARE (Ketamine in the Reduction of Alcoholic Relapse) and is specific to alcohol use disorder, while the other, KAP (Ketamine-Assisted Therapy), is directed to other psychiatric disorders including depression, anxiety, PTSD and addictions.